The S&P 500 Quality FCF Aristocrats seeks out S&P 500 companies that have all of the following traits: High free cash flow ...

Canada was ranked the fifth-most investment-curious country in a recent study, with higher-risk investments like stocks and ...

Have you ever been faced with a difficult decision and been told to “sleep on it”? A new study shows there’s actually ...

Denali Therapeutics remains an intriguing clinical-stage biotech focused on neurodegenerative and lysosomal storage diseases.

As an aging cohort of financial advisors prepares for retirement, firms are scrambling for next-gen talent. Yet a new study ...

Tilray Brands (NasdaqGS:TLRY) has recently published a scientific study through its medical division, comparing the bioavailability of different cannabinoid formulations. This event, paired with the ...

Britain's trees are evolving resistance to the deadly ash dieback fungus, scientists have revealed. The disease has wrought havoc on the countryside, leaving behind the remains of dying ash trees.

Last year’s strong stock-market returns may drive more foundation giving in 2025, and fundraisers should focus on DAF donors.

I Picked a Helluva Time to Retire.’ Six strategies for new retirees facing a dicey stock market and unpredictable economy.

Shares of BP rose Wednesday, lifted by a report that Shell was in talks to acquire it in what would mark a huge deal for the ...

Advancement of long lead work programs to support ML Application HIGHLIGHTS Recent Tunkillia OSS confirms large-scale gold ...

Compass Pathways plc downgraded to Hold after mixed trial results. Explore upcoming catalysts in depression treatment and ...